🔔Stock Alerts via Telegram — Free for All Users

LIEN Stock Risk & Deep Value Analysis

Chicago Atlantic BDC Inc

DVR Score

2.7

out of 10

Risk Trap

What You Need to Know About LIEN Stock

We analyzed Chicago Atlantic BDC Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran LIEN through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.

Updated Apr 21, 2026Run Fresh Analysis →

LIEN Risk Analysis & Red Flags

What Could Go Wrong

The primary risk is federal cannabis legalization. While it could trigger a speculative re-rating, it's more likely to erode LIEN's high-margin competitive moat by inviting traditional, lower-cost lenders into the market, significantly compressing its spreads and profitability. This would fundamentally alter its business model negatively.

Risk Matrix

Overall

Aggressive

Financial

Medium

Market

High

Competitive

High

Execution

Medium

Regulatory

High

Red Flags

  • BDC structure inherently limits capital retention for aggressive equity growth.

  • High dependency on the volatile and uncertain U.S. federal cannabis regulatory landscape.

  • Low Return on Equity (5.88%) despite a strong net margin (33.24%) indicates significant asset base or leverage not translating to high shareholder returns.

  • Director resignation, while amicable, still represents a minor change in governance continuity.

Upcoming Risk Events

  • 📅

    Slower-than-expected progress on cannabis reform

  • 📅

    Increased competition from other lenders in the cannabis space

  • 📅

    Deterioration of credit quality in cannabis borrower portfolio

When to Reconsider

  • 🚪

    Exit if the dividend yield falls significantly without a clear explanation or strategic shift.

  • 🚪

    Sell if there's concrete federal legalization that doesn't include specific protections for existing cannabis lenders, indicating imminent increased competition.

  • 🚪

    Exit if portfolio non-performing loans rise significantly or credit quality deteriorates.

Unlock LIEN Risk Analysis & Red Flags

Create a free account to see the full analysis

Investment Thesis

LIEN offers investors high income generation through its BDC structure, capitalizing on the high-yield, underserved cannabis lending market due to current federal prohibition. While not a 10x growth equity, it provides a unique income stream with a speculative, high-risk, high-reward re-rating potential if federal cannabis reform occurs, provided the company can adapt to a more competitive landscape.

Is LIEN Stock Undervalued?

Chicago Atlantic BDC (LIEN) continues to demonstrate operational effectiveness in the underserved cannabis lending market, as evidenced by its Q4 2025 revenue beat and met EPS. Its regulatory moat allows for strong income generation. However, the fundamental BDC structure mandates significant earnings distribution, inherently limiting capital retention vital for exponential equity growth and a 10x return. While federal legalization could prompt a speculative re-rating, it equally risks eroding LIEN's high-spread competitive advantage by inviting traditional lenders. The company remains a strong income play but lacks the reinvestment capacity and explosive scalability required for 10x equity appreciation within 3-5 years. The recent director resignation was amicable and does not impact operations materially.

Unlock the full AI analysis for LIEN

Get the complete DVR score, risk analysis, and more

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

LIEN Price Targets & Strategy

12-Month Target

$11.00

Bull Case

$13.00

Bear Case

$8.00

Valuation Basis

11.5x trailing P/E applied to annualized Q4 2025 EPS ($0.36 * 4 = $1.44) = $16.56. However, given small-cap BDC nature, a more conservative target of ~12x current price / 1.1x projected EPS = $11.00.

Entry Strategy

Dollar-cost average between $9.00-$9.50, seeking stability around current levels.

Exit Strategy

Take profit at $12.50-$13.00 if significant regulatory catalyst or strong sector tailwinds emerge; consider stop-loss at $8.00 (below recent support).

Portfolio Allocation

1-2% for aggressive risk tolerance (due to sector niche and speculative upside potential).

Price Targets & Strategy

Upgrade to Premium for price targets and entry/exit strategies

Is LIEN Financially Healthy?

Valuation

P/E Ratio

6.50

Forward P/E

13.43

Price/Book

0.77

Price/Sales

7.41

Profitability

Gross Margin

72.61%

Operating Margin

61.29%

Net Margin

61.29%

Return on Equity

11.01%

Revenue Growth

150.64%

EPS

$1.46

Balance Sheet

Current Ratio

0.64

Quick Ratio

0.58

Debt/Equity

0.08

Cash Flow

EBITDA

$24.46M

Other

Beta (Volatility)

0.28

Dividend Yield

14.35%

Does LIEN Have a Competitive Moat?

Sign in to unlock

Moat Rating

🛡️ Narrow

Moat Trend

Stable, but highly susceptible to erosion with federal legalization.

Moat Sources

2 Identified

Intangible Assets (specialized expertise and relationships)Efficient Scale (operating effectively in a niche overlooked by larger players)

The moat is primarily regulatory and relies on the continued federal illegality of cannabis. As long as this persists, LIEN's ability to command high interest rates will endure. However, its durability is limited by potential legislative changes.

Moat Erosion Risks

  • Federal legalization of cannabis, allowing traditional banks to enter the market and compress lending spreads.
  • Increased competition from other specialty finance companies or private credit funds targeting the cannabis sector.
  • Significant changes in state-level cannabis regulations that could impact borrower operations or collateral values.

LIEN Competitive Moat Analysis

Sign up to see competitive advantages

LIEN Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Neutral. Limited retail investor buzz outside of cannabis-specific communities. Sentiment is often tied to federal legalization prospects.

Institutional Sentiment

Neutral. No recent analyst upgrades/downgrades or price targets available in the real-time intelligence. Institutional interest is likely tied to dividend yield and specific cannabis sector theses.

Insider Activity (Form 4)

Director Patrick McCauley resigned effective April 10, 2026, to pursue other opportunities; no disagreements cited. No Form 4 filings for insider buys/sells in the last 90 days were reported.

Options Flow

Normal options activity. No unusual put/call ratios or significant block trades detected in the provided research.

Earnings Intelligence

Next Earnings

2026-05-13

Surprise Probability

Medium

Historical Earnings Pattern

For BDCs, earnings reactions are often muted unless there's a significant beat/miss on NII or a change in dividend policy/guidance. Steady performance typically leads to stable trading.

Key Metrics to Watch

Net Investment Income (NII) and NII per shareDividend coverage ratioPortfolio growth and credit quality trendsManagement commentary on regulatory environment

Competitive Position

Top Competitor

Not explicitly provided, but similar non-bank specialty finance companies or other BDCs focused on niche, high-yield lending such as AFC Gamma (AFCG) or Innovative Industrial Properties (IIPR) (REIT, not BDC, but also cannabis exposure).

Market Share Trend

Stable within its specific niche of cannabis lending. Growth is dependent on expanding state legalization and capital availability.

Valuation vs Peers

Trading at a trailing P/E of 11.95, which is generally in line or at a slight discount to typical BDC valuations, likely reflecting the added regulatory risk of the cannabis sector. More diversified BDCs often trade at a higher multiple.

Competitive Advantages

  • Strong regulatory moat due to federal cannabis illegality limiting traditional bank entry.
  • Specialized underwriting expertise in the complex and evolving cannabis industry.
  • Established relationships within the cannabis ecosystem.

Market Intelligence

Get sentiment, earnings intel, and peer analysis with Premium

What Could Drive LIEN Stock Higher?

Near-Term (0-6 months)

  • Q1 2026 Earnings Report (May 13, 2026)
  • Potential legislative movement on federal cannabis reform

Medium-Term (6-18 months)

  • Expansion of lending portfolio into new state cannabis markets
  • Successful refinancing or expansion of existing credit facilities

Long-Term (18+ months)

  • Federal legalization of cannabis leading to re-rating of the sector
  • Strategic pivot or M&A activity post-legalization

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for LIEN?

  • Progress of federal cannabis reform legislation (e.g., SAFE Banking Act, MORE Act).

  • Trends in net investment income (NII) and dividend distribution consistency.

  • Any major shifts in management's stated strategy regarding capital allocation or diversification.

Bull Case Analysis

See what could go right with Premium

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

How Chicago Atlantic BDC Inc Makes Money

Chicago Atlantic BDC Inc. operates as a Business Development Company (BDC) that specializes in providing senior secured debt financing to companies in the U.S. cannabis industry. Due to federal prohibition, traditional banks are largely unable to serve this market, allowing LIEN to charge higher interest rates. As a BDC, it's legally required to distribute at least 90% of its taxable income to shareholders, making it an income-focused investment rather than a growth-focused one. It essentially functions as a private credit fund for the cannabis sector, funding businesses that would otherwise struggle to access capital.

Read Full Business Model Breakdown

FAQ

What is the DVR Score for Chicago Atlantic BDC Inc (LIEN)?

As of April 21, 2026, Chicago Atlantic BDC Inc has a DVR Score of 2.7 out of 10, placing it in the "Risk Trap" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Chicago Atlantic BDC Inc?

Chicago Atlantic BDC Inc's market capitalization is approximately $216.3M..

What is the risk level for LIEN stock?

Our analysis rates Chicago Atlantic BDC Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of LIEN?

Chicago Atlantic BDC Inc currently has a price-to-earnings (P/E) ratio of 6.5. This is below the market average, which could indicate the stock is undervalued or facing headwinds.

Does Chicago Atlantic BDC Inc pay a dividend?

Yes, Chicago Atlantic BDC Inc pays a dividend with a current yield of approximately 14.35%.

Is Chicago Atlantic BDC Inc's revenue growing?

Chicago Atlantic BDC Inc has reported revenue growth of 150.6%. The company is showing strong top-line momentum.

Is LIEN stock profitable?

Chicago Atlantic BDC Inc has a profit margin of 61.3%. This indicates strong profitability.

How often is the LIEN DVR analysis updated?

Our AI-powered analysis of Chicago Atlantic BDC Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 21, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for LIEN (Chicago Atlantic BDC Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to LIEN Stock Risk & Deep Value Analysis